lncRNA, miRNA, and mRNA of plasma and tumor-derived exosomes of cardiac myxoma-related ischaemic stroke
Quick Facts
- Publication title: lncRNA, miRNA, and mRNA of plasma and tumor-derived exosomes of cardiac myxoma-related ischaemic stroke
- Journal: Sci Data
- Year: 2025
- DOI: 10.1038/s41597-025-04410-4
- PMID/PMCID: 39820519; PMC11739660
Research overview
This dataset provides a significant resource for relevant researchers to explore the potential dysregulated lncRNAs, miRNAs, and mRNAs of plasma and tumour-derived exosomes in CM-IS. Tumour-derived exosomes play a crucial role in tumour growth, metastasis, immune regulation, and monitor disease development.
Key findings
Cardiac myxoma (CM) is an important aetiology of stroke in young adults, and its diagnosis is difficult in patients having stroke because of the lack of diagnostic biomarkers.
Tumour-derived exosomes play a crucial role in tumour growth, metastasis, immune regulation, and monitor disease development.
Hence,we established an RNA-sequencing dataset for long non-coding RNA (lncRNA), microRNA (miRNA), and messenger RNA (mRNA) in the plasma and tumour-derived exosomes from four patients with cardiac myxoma-related ischaemic stroke (CM-IS) and six patients with cardiac myxoma without ischaemic stroke (non-IS CM).
Moreover, 5,533 lncRNAs, 1,331 known miRNAs, and 412 new miRNAs were identified.
Echo Biotech Role
Echo Biotech contributed EV isolation and purification, EV characterization, whole-transcriptome sequencing; the study also used or cited Exosupur®.
Related platforms: Exoomics®, Research Reagents & Tools
Related services and capabilities: Biofluid EV Isolation & Purification, Tissue EV Isolation & Purification, EV Basic Characterization (TEM/NTA/WB), EV Whole-Transcriptome Sequencing, Research Reagent / Product Supply
Related products or reagents: Exosupur® EV Isolation/Purification Kit
References
Original publication: lncRNA, miRNA, and mRNA of plasma and tumor-derived exosomes of cardiac myxoma-related ischaemic stroke Scientific Data. 2025. DOI: 10.1038/s41597-025-04410-4. PMID/PMCID: 39820519; PMC11739660.